Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment
Stephanie Pei Tung Yiu(Beth Israel Deaconess Medical Center), Baochun Zhang(Boston Children's Hospital), Ye Won Cho(Harvard University), Bokai Zhu(Broad Institute), Jordan E. Krull(The Ohio State University), Leonie Frauenfeld, Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Zhangxin Zhao(Beth Israel Deaconess Medical Center), Jia-Ying Joey Lee(Agency for Science, Technology and Research), A.K. Basak(Broad Institute), Bo Zhao(Guilin Medical University), Precious Cramer(Beth Israel Deaconess Medical Center), Dingani Nkosi(Brigham and Women's Hospital), Shoko Kure(Harvard University), Rongting Huang(Stanford Medicine), Jahanbanoo Shahryari(Stanford University), Y Wang(Beth Israel Deaconess Medical Center), Philip Rock(University of Rochester Medical Center), Lit‐Hsin Loo(Agency for Science, Technology and Research), Jia Le Lee(Beth Israel Deaconess Medical Center), Lindsay K. Parmelee(Beth Israel Deaconess Medical Center), Kenneth J. Livak(Broad Institute), Hendrik A. Michel(Beth Israel Deaconess Medical Center), Sam Sadigh(Brigham and Women's Hospital), Nourhan El Ahmar(Brigham and Women's Hospital), Berkay Şímșek(Brigham and Women's Hospital), Chi Ngai Chan(Beth Israel Deaconess Medical Center), Yuzhou Chang(Shanghai Institute of Measurement and Testing Technology), Colm Keane(The University of Queensland), Yao Yu Yeo(Beth Israel Deaconess Medical Center), David M. Kim(Harvard University), Wenrui Wu(National Clinical Research Center for Digestive Diseases), J. Yeung(Beth Israel Deaconess Medical Center), Ce Gao(Brigham and Women's Hospital), Razan Mohanna(Brigham and Women's Hospital), McKayla Van Orden(Dana-Farber Cancer Institute), Wesley S. Lu(Dana-Farber Cancer Institute), Leandra G. Kingsley(Stanford Medicine), Nagendra Dhanikonda(Beth Israel Deaconess Medical Center), Huaying Qiu(Beth Israel Deaconess Medical Center), Reem N. Al-Humadi(Stanford Medicine), Jonathan Brown(University of Dayton), Sahar Nasr(Stanford Medicine), Hongbo Wang(Brigham and Women's Hospital), Xiaojie Jin(The Ohio State University), Shuli Luo(Beth Israel Deaconess Medical Center), Melinda Burgess(Translational Research Institute), Shuqiang Li(Dana-Farber Cancer Institute), Louisa Kaufmann(University Children's Hospital Tübingen), Chia‐Yu Chen(Harvard University)
Cited by 3
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k